RCE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recce Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.515 AUD -1.9% Market Closed

Market Cap: AU$148.9m

	Recce Pharmaceuticals Ltd ASX:RCE	AU
M	Main Street Capital Corp SWB:13M	US
	EchoStar Corp NASDAQ:SATS	US
	Vivendi SE OTC:VIVHY	FR
	National Australia Bank Ltd ASX:NAB	AU
	DoubleVerify Holdings Inc NYSE:DV	US
	G50 Corp Ltd OTC:GFTYF	AU
	Amaroq Minerals Ltd XTSX:AMRQ	CA
R	Rheinmetall AG SWB:RHM	DE
R	Rolls-Royce Holdings PLC OTC:RLLCF	UK
	Acomo NV AEX:ACOMO	NL
D	Danieli & C Officine Meccaniche SpA MIL:DAN	IT
	System1 Group PLC LSE:SYS1	UK

Profitability Summary

Recce Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2.348%

Negative 3Y Average Operating Margin

-592%

Declining Operating Margin

-481% > -2.348%

Negative Net Margin

-2.671%

Negative 3Y Average Net Margin

-655%

Declining Net Margin

-482% > -2.671%

Negative Free Cash Flow Margin

-227%

Negative 3Y Average Free Cash Flow Margin

-166%

Free Cash Flow Margin is Increasing

-459% > -227%

Exceptional ROE

256%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-16.119%

ROIC is Increasing

-4.780% > 907%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.